BN Business News
Add your company to Business Communicator →

Business · 03/06/1994

Food and Drug Administration Issues Final Rule for Over-The-Counter Astringent Drug Products

The Food and Drug Administration (FDA) has issued a final rule updating the monograph for over-the-counter (OTC) astringent drug products, incorporating a United States Pharmacopeia (U.S.P.) name change for an active ingredient.

Original source language: Federal Register — Health and Human ServicesOpen original release →

Explore insights